Financhill
Back

ITeos Therapeutics Quote, Financials, Valuation and Earnings

ITeos Therapeutics Price Quote

$15.73
-0.57 (-3.5%)
(Updated: July 19, 2024 at 5:35 PM ET)

ITeos Therapeutics Key Stats

Buy
66
ITeos Therapeutics (ITOS) is a Buy

Day range:
$16.25 - $17.12
52-week range:
$8.20 - $18.75
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
4.57
P/B ratio:
1.09%

Volume:
163.6K
Avg. volume:
387.3K
1-year change:
19.41%
Market cap:
$588.8M
Revenue:
$12.6M
EPS:
$-3.78

How Much Does ITeos Therapeutics Make?

Data Unavailable

Is ITeos Therapeutics Growing As A Company?

Data Unavailable

ITeos Therapeutics Stock Price Performance

What Is ITeos Therapeutics 52-Week High & Low?

ITeos Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy ITeos Therapeutics?

Is ITeos Therapeutics Cash Flow Positive?

  • What Is ITOS Cash Flow From Operations?
    Cash flow from operations (TTM) is -$109.6M
  • What Is ITeos Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $557K
  • What Is ITeos Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $34.8M

ITeos Therapeutics Return On Invested Capital

Data Unavailable

ITeos Therapeutics Earnings Date & Stock Price

ITeos Therapeutics Competitors

ITeos Therapeutics Dividend Yield

Data Unavailable

ITeos Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -13.96%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 2
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 35.40
Upside from Last Price: 117.18%

Major Shareholders

  • How many ITOS shares are owned by institutional investors?
    46.8M ITOS shares are owned by institutional investors
  • How many ITOS shares are owned by insiders?
    288.2K ITOS shares are owned by insiders